GLENMARK LIFE SCIENCES
Back to Balance Sheet
|
GLENMARK LIFE SCIENCES Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹49 Cr | ₹42 Cr | ₹31 Cr | ₹23 Cr | ₹16 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of GLENMARK LIFE SCIENCES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹49 Cr |
Mar2023 | ₹42 Cr |
Mar2022 | ₹31 Cr |
Mar2021 | ₹23 Cr |
Mar2020 | ₹16 Cr |
How is Deferred Tax Assets / Liabilities of GLENMARK LIFE SCIENCES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹49 Cr | 14.97 | |
Mar2023 | ₹42 Cr | 34.73 | |
Mar2022 | ₹31 Cr | 37.60 | |
Mar2021 | ₹23 Cr | 39.15 | |
Mar2020 | ₹16 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of GLENMARK LIFE SCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK LIFE SCIENCES | ₹13,309.0 Cr | -0.6% | 7% | 70.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹427,478.0 Cr | -1.3% | -4.8% | 45% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,822.0 Cr | 0.5% | 6.4% | 58.2% | Stock Analytics | |
CIPLA | ₹123,920.0 Cr | 2.1% | 3.8% | 24.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,322.0 Cr | -0.6% | -5.7% | 5.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,217.3 Cr | 0.1% | -3.6% | 48.2% | Stock Analytics |
GLENMARK LIFE SCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK LIFE SCIENCES | -0.6% |
7% |
70.9% |
SENSEX | 0.9% |
-0.3% |
20.9% |
You may also like the below Video Courses